Reckitt Must Hand Over Nonprivileged Suboxone Docs To FTC
Law360, New York (March 10, 2015, 8:31 PM EDT) -- A Virginia federal judge on Tuesday order Reckitt Benckiser Pharmaceuticals Inc. to identify and hand over all nonprivileged documents amid a Federal Trade Commission investigation into whether the company tried to prevent generic competition for opiate addiction treatment Suboxone.
Reckitt and the watchdog agency have been bickering in recent months as the FTC tries to force the drugmaker to comply with a civil investigative demand and turn over some 22,000 documents related to Suboxone. The FTC is investigating whether Reckitt used various tactics — including product-hopping and abusing the FDA's safety regulations — to stave off generics competition for the treatment....
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!